An objective of randomized placebo-controlled preventive HIV vaccine efficacy trials is to assess the relationship between the vaccine effect to prevent infection and the genetic distance of the exposing HIV to the HIV strain represented in the vaccine construct.Motivated by this objective, recently a mark-specific proportional hazards model with a continuum of competing risks has been studied,where the genetic distance of the transmitting strain is the continuous mark defined and observable only in failures.